Search

Cookies

We use cookies to improve your experience. By continuing, you accept our use of cookies.

Business

Nuvama Reiterates 'Buy' on Top Insurance Stocks: SBI Life, HDFC Life, Max Financial, ICICI Pru

· · 3 min read

Nuvama Institutional Equities has reiterated 'Buy' ratings for major Indian life insurance stocks, including SBI Life and HDFC Life, citing strong individual retail weighted received premium growth. The brokerage assigned specific target prices for each company.

Nuvama Institutional Equities has reaffirmed its positive outlook on the Indian life insurance sector, reiterating 'Buy' ratings for four prominent players: SBI Life Insurance Company Ltd, HDFC Life Insurance Company Ltd, Max Financial Services Ltd, and ICICI Prudential Life Insurance Company Ltd. The brokerage highlighted robust and broad-based growth in individual retail weighted received premium (RWRP) across the industry.

According to Nuvama, the industry's individual RWRP saw a significant year-on-year (YoY) increase of approximately 21% in April 2026, reaching ₹2,090 crore. Private insurers led this surge with a 22% YoY growth to ₹4,450 crore, while LIC also posted a healthy 19% YoY rise to ₹2,200 crore. This strong performance is partly attributed to a lower base in April 2025.

SBI Life Insurance: A Standout Performer

SBI Life Insurance emerged as a standout performer, reporting an overall Annualized Premium Equivalent (APE) growth of 120% YoY in April 2026, reaching ₹2,090 crore. This was driven by strong growth in both retail (+18% YoY to ₹990 crore) and group segments (+875% YoY to ₹1,100 crore). While group segment growth was largely influenced by lumpy yearly renewals, adjusted overall APE growth stood at 19% YoY, aligning with industry trends. Nuvama maintains a 'Buy' rating with a target price of ₹2,390 for SBI Life.

HDFC Life Insurance: Healthy Premium Growth

HDFC Life Insurance demonstrated healthy premium growth, posting an overall APE growth of 24% YoY to ₹950 crore, with RWRP growing 24% YoY to ₹790 crore. This growth benefited from a low base in April 2025. Over a two-year compound annual growth rate (CAGR), HDFC Life's individual APE grew approximately 13.4%. Nuvama has retained its 'Buy' rating for HDFC Life, setting a target price of ₹850.

Max Financial Services: Consistent Performance

Max Financial Services maintained its positive trajectory, recording an overall APE of ₹440 crore in April 2026 (+15% YoY) and RWRP of ₹430 crore (+21% YoY). This performance comes despite a relatively high base from April 2025. The company has shown consistent APE growth in 35 out of the last 37 months. Nuvama reiterates its 'Buy' rating for Max Financial, with a target price of ₹2,070.

ICICI Prudential Life Insurance: Growth on a Weak Base

ICICI Prudential Life Insurance saw a 24% YoY growth in APE to ₹620 crore, with RWRP increasing by 25% YoY to ₹420 crore. This growth was supported by a weak base in April 2025, which had seen a 16% YoY fall in RWRP. On a two-year CAGR basis, ICICI Prudential reported individual APE growth of approximately 2.5%. Nuvama maintains a 'Buy' rating for ICICI Prudential Life, assigning a target price of ₹750.

Disclaimer: This article provides information for general informational purposes only and should not be considered investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.

Related